Home > Financial Ratios > KREBS BIOCHEMICALS & INDUSTRIES

KREBS BIOCHEMICALS & INDUSTRIES
Core EBITDA Margin

    Back to All Ratios
COMMUNITY POLL
for KREBS BIOCHEMICALS & INDUSTRIES
Please provide your vote to see the results

KREBS BIOCHEMICALS & INDUSTRIES Last 5 Year Core EBITDA Margin History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) -17.30-30.27-56.94-32.73-55.53

What is the latest Core EBITDA Margin ratio of KREBS BIOCHEMICALS & INDUSTRIES ?

The latest Core EBITDA Margin ratio of KREBS BIOCHEMICALS & INDUSTRIES is -17.30 based on Mar2024 Standalone results.
Year Core EBITDA Margin
Mar2024-17.30
Mar2023-30.27
Mar2022-56.94
Mar2021-32.73
Mar2020-55.53

How is Core EBITDA Margin of KREBS BIOCHEMICALS & INDUSTRIES Trending?

Years Core EBITDA Margin % Change
Mar2024 -17.3
Negative
Mar2023 -30.27
Negative
Mar2022 -56.94
Negative
Mar2021 -32.73
Negative
Mar2020 -55.53 -

Other Financial Ratios of KREBS BIOCHEMICALS & INDUSTRIES


Compare Core EBITDA Margin ratio of peers of KREBS BIOCHEMICALS & INDUSTRIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KREBS BIOCHEMICALS & INDUSTRIES ₹166.9 Cr 5.7% 1.5% -6.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹387,792.0 Cr 2.3% -0.4% -12.4% Stock Analytics
DIVIS LABORATORIES ₹159,986.0 Cr 0% 1.1% 10.7% Stock Analytics
CIPLA ₹127,124.0 Cr 2.1% 3.5% -4.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹120,700.0 Cr -1.2% -1.7% 4.5% Stock Analytics
DR REDDYS LABORATORIES ₹109,868.0 Cr 5.3% 7.9% -2% Stock Analytics


KREBS BIOCHEMICALS & INDUSTRIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
KREBS BIOCHEMICALS & INDUSTRIES

5.7%

1.5%

-6.6%

SENSEX

1.5%

1.6%

0.4%


You may also like the below Video Courses